Interview with Hervé Dussart , President, AstraZeneca Turkey
Even though you have delivered strong results in most of the markets you have been appointed, this is your first assignment as the head of a subsidiary. For a man…
Address: Büyükdere Cad. Yapı Kredi Plaza, B Blok, K:2-4, 34330 Levent – Istanbul / Turkey
,Turkey
Tel: +90 212 317 2300
Web: http://www.astrazeneca.com.tr/
Since 1999 with the mission to produce ideas that add value for the life of people spend their lives working for better quality, and performs a lot of research, AstraZeneca, has been undertaking major projects in Turkey within the framework of social responsibility . AstraZeneca to gain awareness of first aid at a young age, ‘First Aid’ project TOÇEV throughout Turkey and in conjunction with the Ministry of National Education conducts. Investigating the effects of socioeconomic and environmental factors on human health and will continue for 10 years, ‘Prospective Urban and Rural Epidemiology’ ‘PURE’ gold sponsor of the research all over the world. Continued under the leadership of our country, METSEND’in approximately 3000 people were included in this project. not only the disease-causing diseases, and investigating the causes and environments that support the work of public awareness in order to eliminate these causes, AstraZeneca, ‘Fast Forward-fast-forward’ approach, using the maximum to produce beneficial drugs, the patient needs to provide the most appropriate solutions and business processes through the developing world to adapt the driving force attack is considered.
AstraZeneca, research, development, prescription drugs, production, marketing and presentation of these services in the field, one of the most important international companies. Volume of $ 33 billion health care and chest infection, cardiology, gastroentereloji, oncology, central nervous system and leading position in diabetes care products offered by area is one of the world’s leading pharmaceutical companies
Even though you have delivered strong results in most of the markets you have been appointed, this is your first assignment as the head of a subsidiary. For a man…
Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the past decade, highlighting how MSD works hand-in-hand with the government to broaden access to…
Raphaël Esposito, director of the French Chamber of Commerce in Turkey, sheds light on issues ranging from venture partnerships to cultural specificities, while underlining Turkey’s capacity to respond to the…
Asli Özelli, newly appointed executive director of AmCham Turkey, discusses the economic landscape of Turkey and its attractiveness for American companies, in addition to highlighting her priorities in her new…
Hande Demirdere, general manager of Pierre Fabre Pharma in Turkey, sheds light on the affiliate’s impressive 93 percent growth in 2017 while highlighting where to target development opportunities in the…
Selim Giray, the recently appointed VP and general manager of GSK Turkey, provides insights into the company’s eye-catching footprint and commitment to Turkey, his ambition to integrate into the market’s…
In Summer 2018, we spoke to Adriano Antonio Treve, then general manager of Roche Turkey, now Area Head Central Eastern Europe, Turkey, Russia, Central Asia, Iran, Pakistan & Indian Subcontinent.…
Elif Aral, country manager of Pfizer Turkey, stresses that Turkey will continue to be perceived as essential and important, where healthcare is a top priority with its young but aging…
Mustafa Kemal Erol , president of the Turkish Society of Cardiology, introduces one of the oldest and largest societies in the country divulges their best collaborations with the Ministry of…
Abdi İbrahim Otsuka, the Turkish-Japanese hybrid pharmaceutical company, celebrated their five-year anniversary just last year and have ambitions to become the Number One Japanese company in Turkey. Elif Elkin, in…
Mark Dekker, general manager of Astellas in Turkey, describes the ever-increasing commitment of the company to Turkey and the recent doubling of Astellas’ portfolio in the country, while pinpointing the…
Mahmut Gümüş, president of the Turkish Society of Medical Oncology, paints a descriptive picture of the oncology situation in the country, with the looming epidemiological shift set to transform the…
Hakan Koçak, CEO–general manager of Koçak Farma, a company with 47 years in the pharmaceutical industry and the biggest production facility in Turkey, gives a thorough insight into Koçak Farma’s…
See our Cookie Privacy Policy Here